共 52 条
- [1] Murray HW(2005)Advances in leishmaniasis Lancet 366 1561-1577
- [2] Berman JD(1996)Leishmaniasis. Public health aspects and control Clin Dermatol 14 417-423
- [3] Davies CR(1999)Leishmaniasis Lancet 354 1191-1199
- [4] Saravia NG(2006)Kala azar. Rare import and significant differential diagnosis Internist (Berl) 47 825-828
- [5] Desjeux P(2006)Diffuse metabolic activation of reticuloendothelium on F-18 FDG PET imaging in a case of visceral leishmania Clin Nucl Med 31 34-36
- [6] Herwaldt BL(1992)Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis Trans R Soc Trop Med Hyg 86 505-507
- [7] Sudeck H(2007)Chemotherapy of leishmaniasis: past, present and future Curr Med Chem 14 1153-1169
- [8] Lupi A(2008)Fever, pancytopenia, and splenomegaly 8 months after a trip to Majorca Island (Spain) Med Klin (Munich) 103 29-35
- [9] Todeschini G(2007)Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5 873-882
- [10] Zanco P(2004)Is leishmaniasis becoming endemic in Germany? Int J Med Microbiol 293 179-181